期刊文献+

hsa_circ_0008934表达水平与三阴性乳腺癌患者新辅助化疗治疗反应的关系 被引量:1

Relationship between hsa_circ_0008934 expression level and response to neoadjuvant chemotherapy in patients with triple negative breast cancer
在线阅读 下载PDF
导出
摘要 目的探讨hsa_circ_0008934在三阴性乳腺癌(TNBC)中的表达及其与新辅助化疗(NACT)治疗反应和预后的相关性。方法选取2016年2月至2019年2月河北省唐山市人民医院肿瘤医院收治的126例行NACT的TNBC患者作为研究对象。分析TNBC组织和癌旁组织中hsa_circ_0008934的表达情况。根据hsa_circ_0008934在TNBC中的表达情况将患者分为高表达组(n=73)和低表达组(n=53),比较两组的基线资料。将hsa_circ_0008934变量纳入和剔除分别建立NACT后TNBC未完全缓解的预测模型,并利用受试者工作特征(ROC)曲线对模型进行评价,利用Bootstrap重复取样方法对模型进行内部验证。结果TNBC组织中hsa_circ_0008934的表达水平明显高于癌旁组织,差异具有统计学意义(P<0.01);临床分期Ⅱ+Ⅲ期、有脉管瘤栓、肿瘤直径≥5cm、区域淋巴结转移、hsa_circ_0008934高表达、MP分级1~3级是NACT后TNBC未完全缓解的独立危险因素(P<0.05);纳入hsa_circ_0008934表达变量的模型具有更高的预测价值(P<0.05)。结论hsa_circ_0008934高表达的TNBC患者对NACT治疗反应不佳,且预后较差。hsa_circ_0008934表达水平可能提示TNBC患者NACT的反应和预后。 Objective To explore the expression of hsa_circ_0008934 in triple negative breast cancer(TNBC)and its correlation with neoadjuvant chemotherapy(NACT)treatment response and prognosis.Methods A total of 126 patients with TNBC who underwent NACT in Tumor Hospital,Tangshan People's Hospital from February2016 to February 2019 were selected.The expression of hsa_circ_0008934 in cancer tissues and paracancerous tissues was analyzed.According to the expression of hsa_circ_0008934 in TNBC,patients were divided into high expression group(n=73)and low expression group(n=53),and the general clinical data of the two groups werecompared.The prediction model of incomplete remission of TNBC after NACT was established by including and eliminating hsa_circ_0008934 variables,and the model was evaluated by subject working characteristic curve(ROC),and was verified by Bootstrap repeated sampling method.Results The expression level of hsa_circ_0008934 in TNBC tissues was higher than that in paracancerous tissues(P<0.01).Clinical stageⅡ+Ⅲ,vascular tumor thrombus,tumor diameter≥5cm,regional lymph node metastasis,high expression of hsa_circ_0008934 andMP grade 1-3 were independent risk factors for incomplete remission after NACT treatment(P<0.05).The modelwith hsa_circ_008934 expression variables had higher predictive value(P<0.05).Conclusions TNBC patientswith high expression of hsa_cinc_0008934 had poor response to NACT treatment and poor prognosis.The level ofhsa_circ_008934 expression may inicate the response and prognosis of NACT therapy in patients with TNBC.
作者 陈晶晶 石鹏 蒋楠 王宏 常猛 崔志超 谷峥 马杰 CHEN Jingjing;SHI Peng;JIANG Nan;WANG Hong;CHANG Meng;CUI Zhichao;GU Zheng;MA Jie(Department of Breast Surgery 1,Tlumor Hospital,Tangshan People's Hospital,Tangshan 063000,Hebei,China;Department of Urology 2,Tlumor Hospital,Tangshan People's Hospital,Tangshan 063000,Hebei,China)
出处 《中国性科学》 2021年第12期57-61,共5页 Chinese Journal of Human Sexuality
基金 2021年河北医学科学研究课题(20211662)。
关键词 hsa_circ_0008934 三阴性乳腺癌 新辅助化疗 预后 相关性 Hsacirc0008934 Triple negative breast cancer Neoadjuvant chemotherapy Prognosis Correlation
作者简介 通讯作者:马杰,E-mail:crystalchen201504@163.com。
  • 相关文献

参考文献10

二级参考文献36

  • 1赵卫红,徐兵河,李青,张频,孙燕.70岁以上老年女性乳腺癌患者的特点和预后分析[J].中华肿瘤杂志,2006,28(5):385-388. 被引量:69
  • 2张毅,姜军,杨新华,封传悦.老年乳腺癌ER、PR表达及其与临床病理的关系[J].第三军医大学学报,2007,29(5):454-456. 被引量:22
  • 3Bauer KR, Brown M, Cress RD, et al. Descriptive analysis of estrogen receptor ( ER ) -negative, progesterone receptor ( PR ) - negative, and HER2-negative invasive breast cancer, the socalled triple-negative phenotype: a population-based study from the California cancer registry [ J]. Cancer, 2007, 109: 1721- 1728.
  • 4Cleator S, Heller W, Coombes RC, et al. Triple-negative breast cancer: therapeutic options [ J ]. Lancet Oncol, 2007, 8: 235- 244.
  • 5Rakha EA, EI-Sayed ME, Green AR, et al. Prognostic markers in trlple-negative breast cancer[ J]. Cancer,2007,109:25-32.
  • 6Morris GJ, Naidu S, Topham AK, et al. Differences in breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients: a single-institution compilation compared with the National Cancer Institute's, Surveillance, Epidemiology, and Ehd Results database [ J ]. Cancer,2007,110:876-884.
  • 7Sharon NM, Maureen T, Harriet K,et al. Patterns of recurrence in the basal and non-basal subtypes of triple-negative breast cancers [ J ]. Breast Cancer Res Treat,2009,118 : 131-137.
  • 8Alessandra G, Maria PS, Paolo P,et al. HER2 status and efficacy of adjuvant anthracyclines in early breast cancer: A pooled analysis of randomized trials [ J]. J Natl Cancer Inst,2008,100:14-20.
  • 9Dent R, Trudeau M, Pritchard KI, et al. Triple-negative breast cancer: clinical features and patterns of recurrence [ J ]. Clin Cancer Res ,2007,13:4429-4434.
  • 10Cornelia L, Chafika M, Kenneth R, et al. Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer[ J ]. J Clin Oncol,2008,26 : 1275-1281.

共引文献124

同被引文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部